Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia. 2012 Sep; 26(9):2103-13.

View in: PubMed

subject areas

Algorithms
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Cyclophosphamide
Doxorubicin
Female
Gene Expression Profiling
Humans
Immunoenzyme Techniques
Immunophenotyping
Lymphoma, Large B-Cell, Diffuse
Male
Middle Aged
Oligonucleotide Array Sequence Analysis
Prednisone
Prognosis
Rituximab
Survival Rate
Tissue Array Analysis
Vincristine

authors with profiles

CARLOS E BUESO-RAMOS
ROBERTO MIRANDA
L JEFFREY MEDEIROS
ZIJUN XU-MONETTE